Rik Derynck

Rik Derynck has made foundational contributions to TGF-beta signaling biology, including the cloning of TGF-beta receptors and the discovery of SMAD-independent (non-canonical) TGF-beta signaling pathways critical for cancer progression. His research demonstrated that TGF-beta activates MAPK, PI3K, and Rho GTPase pathways independently of SMADs to drive EMT, invasion, and metastasis. He defined the molecular mechanisms by which TGF-beta induces EMT through transcription factors Snail, Slug, ZEB1, and Twist. His comprehensive understanding of TGF-beta signaling complexity has informed strategies to selectively target protumorigenic TGF-beta functions while preserving tumor-suppressive effects.